US FDA Grants Breakthrough Designation for Blood Test to Hel

Mumbai (Maharashtra) [India], January 3 (ANI/PRNewswire): Datar Cancer Genetics announced today that the US Food and Drug Administration (FDA) has granted 'Breakthrough Device Designation' for its 'TriNetra-Glio', a blood test to help in the diagnosis of brain tumors

Related Keywords

United States , Mumbai , Maharashtra , India , United Kingdom , London , City Of , Kevin Oneill , Sewanti Limaye , Darshana Patil , Brain Tumor Research Campaign , Drug Administration , Imperial College , Oncology Research , Sir Hn Reliance Foundation Hospital , Breakthrough Devices Program , European Union , Datar Cancer Genetics , Breakthrough Device Designation , Breakthrough Device , Consultant Neurosurgeon , Principal Investigator , Brain Tumor Research Charity , Precision Oncology , Foundation Hospital , Medical Director , Breakthrough Designation , Cancer Genetics , Us , Fda , Migrants , Breakthrough , Resignation , Or , Flood , Pest , O , Help , Diagnose , Inaccessible , Rain , Rumors , News , Ews India ,